JOHANNESBURG - Pharmaceutical company Adcock Ingram said on Tuesday it expected headline earnings per share for the year ended June to rise by 21.6 - 24.8 percent to between 380 cents and 390 cents per share.
Adcock Ingram said it was finalising its results for the financial year, which it expected to release on or about August 29.